Cubist Systematic Strategies, LLC Sage Therapeutics, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $17.3 Billion
- Q1 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 52,523 shares of SAGE stock, worth $566,197. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,523
Previous 22,810
130.26%
Holding current value
$566,197
Previous $494,000
99.19%
% of portfolio
0.01%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$62 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$59.1 Million1.65% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$52.7 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$51.2 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$48.5 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $641M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...